INSMED Inc — Director's Dealing 2022

Jul 8, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2022-07-07

Reporting Person: Lewis William (Director, Chair and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-07	Common Stock	M	96614	$16.16	Acquired	353330	Direct
2022-07-07	Common Stock	S	96614	$23	Disposed	256716	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-07	Stock Option (right to buy)	$16.16	M	96614	Disposed	2026-01-07	Common Stock (96614.0)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: Includes 888 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

F3: This is the weighted average sales price representing 96,614 shares sold at prices ranging from $23.00 to $23.03 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F4: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.